Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Min Qui

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentYuhong Du, Ying Zhou, Min Qui, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 11, 2012
Small molecule antagonist reveals seizure-induced mediation of neuronal injury by prostaglandin E2 receptor subtype EP2Jianxiong Jiang, Thota Ganesh, Yuhong Du, et al.
Assay and Drug Development Technologies|April 11, 2018
Development of a Time-Resolved Fluorescence Resonance Energy Transfer Ultrahigh-Throughput Screening Assay for Targeting the NSD3 and MYC InteractionJinglin Xiong, Valentina Gonzalez Pecchi, Min Qui, et al.
BMC Cancer|January 19, 2006
Comparative effects of RRR-alpha- and RRR-gamma-tocopherol on proliferation and apoptosis in human colon cancer cell linesSharon E Campbell, William L Stone, Steven Lee, et al.
Journal of Molecular Cell Biology|March 15, 2023
TMPRSS2 and SARS-CoV-2 SPIKE interaction assay for uHTSDanielle Cicka, Qiankun Niu, Min Qui, et al.
Assay and Drug Development Technologies|March 15, 2011
A dual-readout F2 assay that combines fluorescence resonance energy transfer and fluorescence polarization for monitoring bimolecular interactionsYuhong Du, Zaneta Nikolovska-Coleska, Min Qui, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2010
Neuroprotection by selective allosteric potentiators of the EP2 prostaglandin receptorJianxiong Jiang, Thota Ganesh, Yuhong Du, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 31, 2010
Reversing chemoresistance by small molecule inhibition of the translation initiation complex eIF4FRegina Cencic, David R Hall, Francis Robert, et al.
ACS Medicinal Chemistry Letters|October 18, 2023
A Novel 7<i>H</i>-[1,2,4]Triazolo[3,4-<i>b</i>]thiadiazine-based Cystic Fibrosis Transmembrane Conductance Regulator Potentiator Directed toward Treatment of Cystic FibrosisAndras Rab, Xun Yang, William F Tracy, et al.
Translational Oncology|June 4, 2023
Bromocriptine monotherapy overcomes prostate cancer chemoresistance in preclinical modelsLijuan Bai, Xin Li, Yang Yang, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentYuhong Du, Ying Zhou, Min Qui, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 11, 2012
Small molecule antagonist reveals seizure-induced mediation of neuronal injury by prostaglandin E2 receptor subtype EP2Jianxiong Jiang, Thota Ganesh, Yuhong Du, et al.
Assay and Drug Development Technologies|April 11, 2018
Development of a Time-Resolved Fluorescence Resonance Energy Transfer Ultrahigh-Throughput Screening Assay for Targeting the NSD3 and MYC InteractionJinglin Xiong, Valentina Gonzalez Pecchi, Min Qui, et al.
BMC Cancer|January 19, 2006
Comparative effects of RRR-alpha- and RRR-gamma-tocopherol on proliferation and apoptosis in human colon cancer cell linesSharon E Campbell, William L Stone, Steven Lee, et al.
Journal of Molecular Cell Biology|March 15, 2023
TMPRSS2 and SARS-CoV-2 SPIKE interaction assay for uHTSDanielle Cicka, Qiankun Niu, Min Qui, et al.
Assay and Drug Development Technologies|March 15, 2011
A dual-readout F2 assay that combines fluorescence resonance energy transfer and fluorescence polarization for monitoring bimolecular interactionsYuhong Du, Zaneta Nikolovska-Coleska, Min Qui, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2010
Neuroprotection by selective allosteric potentiators of the EP2 prostaglandin receptorJianxiong Jiang, Thota Ganesh, Yuhong Du, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 31, 2010
Reversing chemoresistance by small molecule inhibition of the translation initiation complex eIF4FRegina Cencic, David R Hall, Francis Robert, et al.
ACS Medicinal Chemistry Letters|October 18, 2023
A Novel 7<i>H</i>-[1,2,4]Triazolo[3,4-<i>b</i>]thiadiazine-based Cystic Fibrosis Transmembrane Conductance Regulator Potentiator Directed toward Treatment of Cystic FibrosisAndras Rab, Xun Yang, William F Tracy, et al.
Translational Oncology|June 4, 2023
Bromocriptine monotherapy overcomes prostate cancer chemoresistance in preclinical modelsLijuan Bai, Xin Li, Yang Yang, et al.
Pageof 4